Bio-Techne (TECH) - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US09073M1045

Proteins, Antibodies, Reagents, Instruments, Diagnostics, Assays, Genomics

Bio-Techne Corporation is a leading life science company that develops, manufactures, and sells a wide range of innovative products and services for the research and clinical diagnostic markets globally. With a strong presence in the United States, the United Kingdom, Europe, Middle East, Africa, Greater China, and Asia-Pacific, the company operates through two main segments: Protein Sciences and Diagnostics and Genomics.

The Protein Sciences segment is dedicated to developing and manufacturing high-quality biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy. This includes cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. Additionally, the segment offers advanced proteomic analytical tools, such as automated western blot and multiplexed ELISA workflow, for protein analysis in various biological fluids.

The Diagnostics and Genomics segment focuses on developing and manufacturing diagnostic products for the regulated diagnostics market. This includes controls, calibrators, and diagnostic assays, as well as exosome-based molecular diagnostic assays and advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis. The segment also offers genetic and oncology kits for research and clinical applications, as well as instruments and process control products for hematology, blood chemistry, and gases, and coagulation controls and reagents used in various diagnostic applications.

With a rich history dating back to 1976, Bio-Techne Corporation, formerly known as Techne Corporation, has evolved significantly since its inception. The company changed its name to Bio-Techne Corporation in November 2014 and is headquartered in Minneapolis, Minnesota. Today, Bio-Techne Corporation is a renowned name in the life science industry, committed to advancing scientific discovery and improving human health.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for Bio-Techne (TECH) - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for Bio-Techne (TECH) - Stock Price & Dividends

TECH Stock Overview

Market Cap in USD 11,956m
Sector Healthcare
Industry Biotechnology
GiC SubIndustry Life Sciences Tools & Services
TER 0.00%
IPO / Inception 1989-02-09

TECH Stock Ratings

Growth 5y 16.7
Fundamental 65.4
Dividend 4.99
Rel. Performance vs Sector -1.48
Analysts 4.27/5
Fair Price Momentum 66.84 USD
Fair Price DCF 43.68 USD

TECH Dividends

Yield 12m 0.43%
Yield on Cost 5y 0.64%
Dividends CAGR 5y 0.00%
Payout Consistency 96.0%

TECH Growth Ratios

Growth 12m -3.43%
Growth Correlation 12m -10%
Growth Correlation 3m 28%
CAGR 5y 7.96%
CAGR/Mean DD 5y 0.36
Sharpe Ratio 12m -0.25
Alpha vs SP500 12m -31.18
Beta vs SP500 5y weekly 1.01
ValueRay RSI 24.46
Volatility GJR Garch 1y 32.82%
Price / SMA 50 -1.07%
Price / SMA 200 4.93%
Current Volume 1578.3k
Average Volume 20d 889.7k

External Links for TECH Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of TECH stocks?
As of June 22, 2024, the stock is trading at USD 73.66 with a total of 1,578,266 shares traded.
Over the past week, the price has changed by -2.91%, over one month by -10.91%, over three months by +1.94% and over the past year by -3.47%.
What are the forecast for TECH stock price target?
According to ValueRays Forecast Model, TECH Bio-Techne will be worth about 74.4 in June 2025. The stock is currently trading at 73.66. This means that the stock has a potential upside of +1.02%.
Issuer Forecast Upside
Wallstreet Target Price 83.8 13.7
Analysts Target Price 101 37.1
ValueRay Target Price 74.4 1.02